M. Phillips

A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.

R. Herrmann, R. Leong, M. Sparrow, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.

J. Regan, J. W. Smith, John W. Smith, 2004, Seminars in oncology.

Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study

Matthew P Wright, R. Herrmann, K. Shaw, 2012, International Journal of Hematology.

Role of first-line anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy in advanced colorectal cancer: a meta-analysis of randomized clinical trials.

M. Khattak, A. Davidson, M. Phillips, 2015, Clinical colorectal cancer.

Low expression of Granzyme B in colorectal cancer is associated with signs of early metastastic invasion

B. Iacopetta, C. Platell, P. Salama, 2011, Histopathology.

Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial.

W. Urba, R. Ahmad, M. Whiteford, 2022, The Lancet. Oncology.

Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.

N. Zeps, B. Iacopetta, D. Joseph, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking

T. Crocenzi, R. Ahmad, A. Alice, 2020, Nature Communications.

Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma

P. Newell, A. Alice, Shelly A Bambina, 2019, PloS one.

TGFβ suppresses CD8+ T cell expression of CXCR3 and tumor trafficking

T. Crocenzi, R. Ahmad, A. Alice, 2020, Nature Communications.

A Phase II Trial of TGFβ Type I Receptor Inhibitor, Galunisertib, plus Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

W. Urba, G. Vaccaro, M. Crittenden, 2022, International Journal of Radiation Oncology*Biology*Physics.